[1]

Xu Y, Wang D, Fan W, Mu X, Chen J. 2009. Traditional chinese biotechnology. In Biotechnology in China II: Chemicals, Energy and Environment, eds Tsao GT, Ouyang P, Chen J. Berlin: Springer Berlin Heidelberg. pp. 189−233 doi: 10.1007/10_2008_36
[2]

Yao F, Yi B, Shen C, Tao F, Liu Y, et al. 2015. Chemical analysis of the Chinese liquor Luzhoulaojiao by comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry. Scientific Reports 5:9553

doi: 10.1038/srep09553
[3]

Zheng XW, Han BZ. 2016. Baijiu (白酒), Chinese liquor: history, classification and manufacture. Journal of Ethnic Foods 3:19−25

doi: 10.1016/j.jef.2016.03.001
[4]

Wu C, Xing X, Liu G, Su D, Li A, et al. 2022. Effects of Nongxiangxing Baijiu (Chinese liquor) on mild alcoholic liver injury revealed by non-target metabolomics using ultra-performance liquid chromatography quadrupole-time-of-flight mass spectrometry. Journal of Bioscience and Bioengineering 134:62−69

doi: 10.1016/j.jbiosc.2022.04.003
[5]

Bate C, Williams A. 2011. Ethanol protects cultured neurons against amyloid-β and α-synuclein-induced synapse damage. Neuropharmacology 61:1406−1412

doi: 10.1016/j.neuropharm.2011.08.030
[6]

Muñoz G, Urrutia JC, Burgos CF, Silva V, Aguilar F, et al. 2015. Low concentrations of ethanol protect against synaptotoxicity induced by Aβ in hippocampal neurons. Neurobiology of Aging 36:845−856

doi: 10.1016/j.neurobiolaging.2014.10.017
[7]

Gémes K, Forsell Y, Janszky I, László KD, Lundin A, et al. 2019. Moderate alcohol consumption and depression - a longitudinal population-based study in Sweden. Acta Psychiatrica Scandinavica 139:526−535

doi: 10.1111/acps.13034
[8]

Lu J, Xu X, Huang Y, Li T, Ma C, et al. 2021. Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study. The Lancet Psychiatry 8:981−990

doi: 10.1016/S2215-0366(21)00251-0
[9]

Trivedi MH, Daly EJ. 2008. Treatment strategies to improve and sustain remission in major depressive disorder. Dialogues in Clinical Neuroscience 10:377−384

doi: 10.31887/DCNS.2008.10.4/mhtrivedi
[10]

Qaseem A, Barry MJ, Kansagara D. 2016. Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder: a clinical practice guideline from the American college of physicians. Annals of Internal Medicine 164:350−359

doi: 10.7326/M15-2570
[11]

Donroe JH, Edelman EJ. 2022. Alcohol use. Annals of Internal Medicine 175:ITC145−ITC160

doi: 10.7326/aitc202210180
[12]

Cronce JM, Zimmerman L, Rhew IC, Cadigan JM, Atkins DC, et al. 2020. Does it work and does it last? Effects of social and drinking behavior on same-and next-day mood. Addictive Behaviors 100:106111

doi: 10.1016/j.addbeh.2019.106111
[13]

Sanchez K, Hall LR, da Graca B, Bennett MM, Powers MB, et al. 2023. The experience of COVID-19 among people with depression: impact on daily life and coping strategies. Journal of Affective Disorders 321:59−65

doi: 10.1016/j.jad.2022.10.037
[14]

Pinto B, Conde T, Domingues I, Domingues MR. 2022. Adaptation of lipid profiling in depression disease and treatment: a critical review. International Journal of Molecular Sciences 23:2032

doi: 10.3390/ijms23042032
[15]

Gea A, Beunza JJ, Estruch R, Sánchez-Villegas A, Salas-Salvadó J, et al. 2013. Alcohol intake, wine consumption and the development of depression: the PREDIMED study. BMC Medicine 11:192

doi: 10.1186/1741-7015-11-192
[16]

Barrenha GD, Coon LE, Chester JA. 2011. Effects of alcohol on the acquisition and expression of fear-potentiated startle in mouse lines selectively bred for high and low alcohol preference. Psychopharmacology 218:191−201

doi: 10.1007/s00213-011-2285-5
[17]

Dhir A, Malik S, Kessar SV, Singh KN, Kulkarni SK. 2011. Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1, 2, 3, 4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a β-substituted phenylethylamine in mice. European Neuropsychopharmacology 21:705−714

doi: 10.1016/j.euroneuro.2010.12.003
[18]

Golden SA, Covington III HE, Berton O, Russo SJ. 2011. A standardized protocol for repeated social defeat stress in mice. Nature Protocols 6:1183−1191

doi: 10.1038/nprot.2011.361
[19]

Vuralli D, Wattiez AS, Russo AF, Bolay H. 2019. Behavioral and cognitive animal models in headache research. The Journal of Headache and Pain 20:11

doi: 10.1186/s10194-019-0963-6
[20]

Liu MY, Yin CY, Zhu LJ, Zhu XH, Xu C, et al. 2018. Sucrose preference test for measurement of stress-induced anhedonia in mice. Nature Protocols 13:1686−1698

doi: 10.1038/s41596-018-0011-z
[21]

Belujon P, Grace AA. 2017. Dopamine system dysregulation in major depressive disorders. The International Journal of Neuropsychopharmacology 20:1036−1046

doi: 10.1093/ijnp/pyx056
[22]

Joca SR, Guimarães FS. 2006. Inhibition of neuronal nitric oxide synthase in the rat hippocampus induces antidepressant-like effects. Psychopharmacology 185:298−305

doi: 10.1007/s00213-006-0326-2
[23]

Maxwell MA, Cole DA. 2009. Weight change and appetite disturbance as symptoms of adolescent depression: toward an integrative biopsychosocial model. Clinical Psychology Review 29:260−273

doi: 10.1016/j.cpr.2009.01.007
[24]

Atrooz F, Alrousan G, Hassan A, Salim S. 2022. Early-life sleep deprivation enhanced alcohol consumption in adolescent rats. Frontiers in Neuroscience 16:856120

doi: 10.3389/fnins.2022.856120
[25]

Cinelli MA, Do HT, Miley GP, Silverman RB. 2020. Inducible nitric oxide synthase: regulation, structure, and inhibition. Medicinal Research Reviews 40:158−189

doi: 10.1002/med.21599
[26]

Gu Y, Zhu D. 2021. nNOS-mediated protein-protein interactions: promising targets for treating neurological and neuropsychiatric disorders. The Journal of Biomedical Research 35:1

doi: 10.7555/JBR.34.20200108
[27]

Doucet MV, Harkin A, Dev KK. 2012. The PSD-95/nNOS complex: new drugs for depression? Pharmacology & Therapeutics 133:218−229

doi: 10.1016/j.pharmthera.2011.11.005
[28]

Dhir A, Kulkarni SK. 2011. Nitric oxide and major depression. Nitric Oxide 24:125−131

doi: 10.1016/j.niox.2011.02.002
[29]

Zhang H, Sun Y, Qian S, Ge R, Guo X, et al. 2020. Yueju-Ganmaidazao Decoction confers rapid antidepressant-like effects and the involvement of suppression of NMDA/NO/cGMP signaling. Journal of Ethnopharmacology 250:112380

doi: 10.1016/j.jep.2019.112380
[30]

Hornemann T. 2021. Mini review: lipids in peripheral nerve disorders. Neuroscience Letters 740:135455

doi: 10.1016/j.neulet.2020.135455
[31]

Roux A, Jackson SN, Muller L, Barbacci D, O'Rourke J, et al. 2016. Ethanol induced brain lipid changes in mice assessed by mass spectrometry. ACS Chemical Neuroscience 7:1148−1156

doi: 10.1021/acschemneuro.6b00120
[32]

Brydges CR, Bhattacharyya S, Dehkordi SM, Milaneschi Y, Penninx B, et al. 2022. Metabolomic and inflammatory signatures of symptom dimensions in major depression. Brain, Behavior, and Immunity 102:42−52

doi: 10.1016/j.bbi.2022.02.003
[33]

Pu J, Liu Y, Zhang H, Tian L, Gui S, et al. 2021. An integrated meta-analysis of peripheral blood metabolites and biological functions in major depressive disorder. Molecular Psychiatry 26:4265−4276

doi: 10.1038/s41380-020-0645-4
[34]

Huang T, Balasubramanian R, Yao Y, Clish CB, Shadyab AH, et al. 2021. Associations of depression status with plasma levels of candidate lipid and amino acid metabolites: a meta-analysis of individual data from three independent samples of US postmenopausal women. Molecular Psychiatry 26:3315−3327

doi: 10.1038/s41380-020-00870-9
[35]

Faria R, Santana MM, Aveleira CA, Simões C, Maciel E, et al. 2014. Alterations in phospholipidomic profile in the brain of mouse model of depression induced by chronic unpredictable stress. Neuroscience 273:1−11

doi: 10.1016/j.neuroscience.2014.04.042
[36]

Oliveira TG, Chan RB, Bravo FV, Miranda A, Silva RR, et al. 2016. The impact of chronic stress on the rat brain lipidome. Molecular Psychiatry 21:80−88

doi: 10.1038/mp.2015.14
[37]

Joffre J, Hellman J, Ince C, Ait-Oufella H. 2020. Endothelial responses in sepsis. American Journal of Respiratory and Critical Care Medicine 202:361−370

doi: 10.1164/rccm.201910-1911TR
[38]

Pacher P, Beckman JS, Liaudet L. 2007. Nitric oxide and peroxynitrite in health and disease. Physiological Reviews 87(1):315−424

doi: 10.1152/physrev.00029.2006
[39]

Poitelon Y, Kopec AM, Belin S. 2020. Myelin fat facts: an overview of lipids and fatty acid metabolism. Cells 9:812

doi: 10.3390/cells9040812